Drug Profile
House dust mite allergy vaccine - Novozymes
Alternative Names: Allergy vaccine - NovozymesLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Novozymes A/S
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 07 Nov 2005 Discontinued - Preclinical for Allergy in Denmark (unspecified route)
- 02 Jun 2005 The house dust mite allergy vaccine has been outlicensed
- 08 Jun 2004 Preclinical trials in Allergy in Denmark (unspecified route)